LADENBURG THALMANN FINANCIAL SERVICES INC. - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2019$0–1810.0%0.00%–
Q3 2019$0–1810.0%0.00%–
Q2 2019$0–1810.0%0.00%–
Q1 2019$0–1810.0%0.00%–
Q4 2018$0–181
-13.4%
0.00%–
Q3 2018$0–209–0.00%–
 Download
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q4 2019.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders